Low incidence of viral complications after in vivo and in vitro T-cell depletion using low dose alemtuzumab is due to early post transplant outgrowth of protective virus specific CD4 and CD8 memory T-cells by various escape mechanisms
Author(s):
Halkes, C.; Falkenburg, J.H.F.; Egmond, E. van; Meent, M. van; Borne, P. von dem; Marijt, W.A.F.; Veelken, J.H.; Jedema, I.
Published
2012
Publication type
Article / Letter to editor
Date issued
2012-04-30
Language
English
Is part of
Bone Marrow Transplantation (2012), Vol. 47, p. S31-S31
